Insider · CIK 0001005483
Charles E Sheedy
Files at AURX (Nuo Therapeutics, Inc.). First filing Dec 20, 2023, latest Aug 1, 2025.
In brief
Charles E Sheedy files SEC Form 4 as 10% owner at AURX (Nuo Therapeutics, Inc.). Since Dec 20, 2023, Charles E Sheedy has reported 2 open-market buys worth $275k and 0 open-market sells worth $0, the latest filed on Aug 1, 2025.
A track record needs three past buys with six months of prices behind them; Charles E Sheedy has 1, so none is measured yet.
The newest scored trade: bought $200k of AURX on Jul 30, 2025, filed Aug 1, 2025, scored 19 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURX: Nuo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | AURXbuy Nuo Therapeutics, Inc. | $200k 133,333 shares | +1% | - | |
| 23Weak | AURXbuy Nuo Therapeutics, Inc. | $75k 150,000 shares | +1% | +16% from low-85% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | AURX Nuo Therapeutics, Inc. | POpen-market purchase Common Stock | +133,333 | $1.50 | $200k | 11,570,833 | Aug 1, 2025 |
| Dec 19, 2023 | AURX Nuo Therapeutics, Inc. | POpen-market purchase Common Stock | +150,000 | $0.50 | $75k | 11,212,500 | Dec 20, 2023 |
Questions about Charles E Sheedy
Answered from the filings on this page, as of the latest one.
Is Charles E Sheedy buying or selling?
Not in the last 12 months. Charles E Sheedy's latest open-market trade on SEC Form 4 was bought $200k of AURX on Jul 30, 2025.
How did Charles E Sheedy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles E Sheedy has 1.
Where does Charles E Sheedy file Form 4?
Charles E Sheedy has filed Form 4 at AURX (Nuo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.